Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Anabel Priego-Corredor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Teaching Hospital of the Catholic University of Valencia (VTHCUV), Valencia, Spain. Hauptthemen laut MEDLINE: Cat Diseases, Fibrinolysis, Blood Coagulation Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hyperfibrinolysis (HFL) has not been well described in cats. Hypothesis/Objectives Identify risk factors associated with HFL in cats and evaluate its association with survival. Our hypotheses were that cats share similar conditions as dogs and humans with HFL and that it is associated with a worse prognosis. Animals A total of 154 client-owned cats had thromboelastography (TEG) performed because of a variety of clinical conditions.
Methods
Retrospective case–control study. Cases were defined as cats with HFL (clot lysis at 30 min [LY30] ≥ 5% or clot lysis at 60 min [LY60] ≥ 10% or both) and controls were cats that had TEG performed but without HFL. Signalment, conditions that may alter fibrinolysis, TEG variables, indications to perform TEG, and outcome were recorded.
Results
Fifty-two cats (33.8%) with HFL and 102 controls (66.2%) were included. Demographic variables were similar between groups. Both liver disease (odds ratio [OR], 5.0; 95% confidence interval [CI], 2.4–10.6; p < 0.001) and the presence of cavitary effusion (OR, 5.9; 95% CI, 2.8–12.4; p < 0.001) were important risk factors for HFL. Cats with heart disease were less likely to have HFL (OR, 0.2; 95% CI, 0.1–0.5; p < 0.001). The presence of HFL was not associated with worse outcome (p = 0.84). Cats with HFL more often were hypocoagulable, whereas cats without HFL more often were hypercoagulable (p < 0.001). Conclusions and Clinical Importance Liver disease and cavitary effusion are risk factors for HFL in cats. The presence of HFL did not affect survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Veterinary Teaching Hospital of the Catholic University of Valencia (VTHCUV), Valencia, Spain.
- AniCura Valencia Sur Veterinary Hospital, Internal Medicine, Silla, Spain.
ORCID-Profile: Anabel Priego-Corredor
Zitieren
APA
Priego-Corredor, A., Del Saiz-Álvarez, M. R., Vila-Soriano, A., Castro-López, J., & Herrería-Bustillo, V. (2025). Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70201
Vancouver
Priego-Corredor A, Del Saiz-Álvarez MR, Vila-Soriano A, Castro-López J, Herrería-Bustillo V. Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70201
BibTeX
@article{PriegoCorredor2025,
author = {Priego-Corredor, Anabel and Del Saiz-Álvarez, María Rocío and Vila-Soriano, Anna and Castro-López, Jorge and Herrería-Bustillo, Vicente},
title = {Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70201}
}
EUVIMED